Empty Capsules Market Is Estimated To Witness High Growth Owing To Increasing Demand for Gelatin Capsules
Empty Capsules Market |
The global Empty Capsules Market is estimated to be valued at US$ 2,382.7 million in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Empty capsules are widely used in the pharmaceutical and nutraceutical
industries for encapsulating drugs, vitamins, and supplements. They provide
several advantages, such as easy swallowing, precise dosage measurement, and
protection against the degradation of active pharmaceutical ingredients. The
need for empty capsules is associated with the increasing demand for
personalized healthcare and the growing prevalence of chronic diseases.
Additionally, the expanding geriatric population and rising consumer preference
for capsule formulations over tablets are driving the market growth.
Market Key Trends:
One key trend driving the empty capsules market is the increasing demand for
gelatin capsules. Gelatin capsules are the most commonly used type of empty
capsules due to their excellent bioavailability, compatibility with a wide
range of active pharmaceutical ingredients, and easy formulation process.
Gelatin capsules are also preferred by consumers due to their ease of
swallowing and quick disintegration in the gastrointestinal tract. Moreover,
advancements in gelatin technology, such as the development of enteric-coated
and flavored gelatin capsules, are further fueling their demand in the market.
The rising adoption of gelatin capsules by pharmaceutical and nutraceutical
manufacturers is expected to drive the market growth during the forecast
period.
PEST Analysis:
Political: The political factors influencing the empty capsules market include
government regulations on pharmaceutical products, intellectual property
rights, and trade policies. These factors can impact the market by affecting
the ease of doing business and the entry of new players.
Economic: The economic factors affecting the empty capsules market include
disposable income levels, healthcare spending, and currency exchange rates.
Economic downturns can lead to reduced consumer spending on pharmaceutical
products, which may affect the market growth.
Social: The social factors influencing the empty capsules market include
population demographics, healthcare awareness, and cultural attitudes towards
pharmaceutical products. Increasing healthcare consciousness among consumers
and a growing aging population are key drivers for the market.
Technological: Technological advancements such as automated capsule filling
machines and improved manufacturing processes are driving the growth of the
empty capsules market. These advancements help in increasing production
efficiency and reducing costs, thereby contributing to market growth.
Key Takeaways:
The global
empty capsules market is expected to witness high growth, exhibiting a
CAGR of 8.1% over the forecast period. This growth can be attributed to various
factors, including increasing pharmaceutical industry activity, rising consumer
preference for oral drug delivery systems, and the advantages offered by empty
capsules such as ease of administration and precise dosing.
In terms of regional analysis, Asia-Pacific is expected to be the
fastest-growing and dominating region in the empty capsules market. This can be
attributed to the presence of a large patient population, increasing healthcare
infrastructure, and growing pharmaceutical manufacturing activities in
countries like China and India.
Key players operating in the empty capsules market include ACG Group, Capsugel
(Lonza Group AG), Qualicaps, Inc., Bright Pharma Caps, Inc., Sunil Healthcare
Ltd., CapsCanada Corporation, Roxlor LLC, Snail Pharma Industry Co., Ltd.,
Suheung Co., Ltd., and Medi-Caps Ltd. These companies dominate the market
through their extensive product portfolio, global presence, and strategic
collaborations and acquisitions.
In conclusion, the empty capsules market is expected to experience significant
growth over the forecast period. Factors such as favorable government
regulations, increasing healthcare awareness, technological advancements, and
the presence of key players contribute to this growth. The Asia-Pacific region
is expected to be the fastest-growing market, driven by factors like a large
patient population and expanding pharmaceutical industry.
Comments
Post a Comment